Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

NCT06031246 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

634

Enrollment

OTHER

Sponsor class

Conditions

Lung Adenocarcinoma
Lymph Node Metastasis

Interventions

PROCEDURE: Selective Lymph Node Dissection

Sponsor

Fudan University